Could a natural protein help control blood sugar in type 2 diabetes?
NCT ID NCT02724566
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tested whether a protein called apelin can improve how the body uses insulin in people with type 2 diabetes. Nine volunteers received both apelin and a placebo infusion to compare effects. The goal was to see if apelin increases the amount of sugar the body can process, which could lead to better blood sugar control.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- apelin (a synthetic version of a natural protein, given as an infusion)
- What this could lead to
- If it works, this could point toward a new way to improve insulin sensitivity in type 2 diabetes.
- What could go wrong
- This is a very small, early-phase trial with only 9 participants. It is designed to test safety and basic effects, not to prove a treatment works.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospitals of Toulouse (Rangueil)
Toulouse, Midi-Pyrénées, 31059, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Daily pill could offer new hope for weight loss in east asian adults
- Blood test could predict who faces rapid kidney decline in diabetes
- Blood test may predict kidney decline in diabetes — a large trial investigates
- Hormone clue may unmask kidney danger in diabetes
- Can a single pill tackle both fatty liver and diabetes?
- Does when you eat carbs and protein reshape blood sugar control?